Meritage Portfolio Management Eli Lilly & CO Transaction History

Meritage Portfolio Management

$1.63 Billion
Q3 2024

A detailed history of Meritage Portfolio Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Meritage Portfolio Management holds 6,428 shares of LLY stock, worth $4.81 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares

6,428

Previous 6,428 -0.0%

Holding current value

$4.81 Million

Previous $5.82 Million 2.15%

% of portfolio

0.35%

Previous 0.37%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$724.87 - $909.04 $2,174 - $2,727	3 Added 0.05%	6,428 $5.82 Million
Q1 2024 Apr 29, 2024	BUY	$592.2 - $792.28 $28,425 - $38,029	48 Added 0.75%	6,425 $5 Million
Q4 2023 Feb 02, 2024	BUY	$525.19 - $619.13 $634,429 - $747,909	1,208 Added 23.37%	6,377 $3.72 Million
Q3 2023 Oct 30, 2023	BUY	$434.7 - $599.3 $29,994 - $41,351	69 Added 1.35%	5,169 $2.78 Million
Q2 2023 Jul 31, 2023	BUY	$350.74 - $468.98 $17,537 - $23,449	50 Added 0.99%	5,100 $2.39 Million
Q3 2022 Oct 25, 2022	BUY	$296.48 - $337.87 $14,824 - $16,893	50 Added 1.0%	5,050 $1.63 Million
Q4 2021 Jan 28, 2022	SELL	$224.85 - $279.04 $49,916 - $61,946	-222 Reduced 4.25%	5,000 $1.38 Million
Q2 2021 Jul 26, 2021	SELL	$180.55 - $233.54 $6,860 - $8,874	-38 Reduced 0.72%	5,222 $1.2 Million
Q1 2021 Apr 27, 2021	SELL	$164.32 - $212.72 $3.2 Million - $4.14 Million	-19,444 Reduced 78.71%	5,260 $983,000
Q4 2020 Feb 03, 2021	BUY	$130.46 - $172.63 $149,376 - $197,661	1,145 Added 4.86%	24,704 $4.17 Million
Q3 2020 Oct 26, 2020	BUY	$146.22 - $169.13 $2.68 Million - $3.1 Million	18,302 Added 348.15%	23,559 $3.49 Million
Q2 2020 Jul 27, 2020	BUY	$136.42 - $164.18 $4,774 - $5,746	35 Added 0.67%	5,257 $863,000
Q4 2019 Jan 27, 2020	BUY	$106.92 - $132.43 $2,352 - $2,913	22 Added 0.42%	5,222 $686,000
Q2 2019 Jul 30, 2019	SELL	$110.79 - $129.32 $12,408 - $14,483	-112 Reduced 2.11%	5,200 $576,000
Q1 2019 Apr 25, 2019	SELL	$111.31 - $131.02 $556 - $655	-5 Reduced 0.09%	5,312 $689,000
Q4 2018 Jan 25, 2019	BUY	$105.9 - $118.64 $32,299 - $36,185	305 Added 6.09%	5,317 $615,000
Q3 2018 Oct 30, 2018	SELL	$85.86 - $107.31 $1,030 - $1,287	-12 Reduced 0.24%	5,012 $538,000
Q2 2018 Jul 25, 2018	BUY	$75.7 - $86.88 $1,741 - $1,998	23 Added 0.46%	5,024 $429,000
Q4 2017 Jan 29, 2018	SELL	$81.94 - $87.89 $81 - $87	-1 Reduced 0.02%	5,001 $422,000
Q3 2017 Oct 16, 2017	BUY	$77.07 - $85.54 $385,504 - $427,871	5,002	5,002 $428,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meritage Portfolio Management, based on Form 13F filings with the SEC.

News

Stay updated on Meritage Portfolio Management with notifications on news.

Account

Meritage Portfolio Management Eli Lilly & CO Transaction History